149 related articles for article (PubMed ID: 31588566)
21. IgM paraproteinaemia: disease associations and laboratory features.
Roberts-Thomson PJ; Nikoloutsopoulos T; Smith AJ
Pathology; 2002 Aug; 34(4):356-61. PubMed ID: 12190295
[TBL] [Abstract][Full Text] [Related]
22. Neuropathy and monoclonal gammopathy.
Nobile-Orazio E
Handb Clin Neurol; 2013; 115():443-59. PubMed ID: 23931795
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological correlates of IgM paraproteinemias.
Owen RG; Parapia LA; Higginson J; Misbah SA; Child JA; Morgan GJ; Jack AS
Clin Lymphoma; 2000 Jun; 1(1):39-43; discussion 44-5. PubMed ID: 11707811
[TBL] [Abstract][Full Text] [Related]
24. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
[TBL] [Abstract][Full Text] [Related]
25. Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature.
Gomez A; Hoffman JE
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):e101-8. PubMed ID: 27245314
[No Abstract] [Full Text] [Related]
26. Monoclonal gammopathy and neuropathy.
Ramchandren S; Lewis RA
Curr Opin Neurol; 2009 Oct; 22(5):480-5. PubMed ID: 19625962
[TBL] [Abstract][Full Text] [Related]
27. Rituximab treatment provides no clinical benefit in patients with pretreated advanced multiple myeloma.
Zojer N; Kirchbacher K; Vesely M; Hübl W; Ludwig H
Leuk Lymphoma; 2006 Jun; 47(6):1103-9. PubMed ID: 16840202
[TBL] [Abstract][Full Text] [Related]
28. [Peripheral neuropathy with monoclonal gammopathy].
Meier T; Meyer M
Schweiz Med Wochenschr; 1990 Mar; 120(12):417-25. PubMed ID: 2157280
[TBL] [Abstract][Full Text] [Related]
29. Severe motor-dominant neuropathy with IgM M-protein binding to the NeuAcalpha2-3Galbeta- moiety.
Oga T; Kusunoki S; Fujimura H; Kuboki T; Yoshida T; Takai T
J Neurol Sci; 1998 Jan; 154(1):4-7. PubMed ID: 9543315
[TBL] [Abstract][Full Text] [Related]
30. Acute inflammatory neuropathy with monoclonal anti-GM2 IgM antibodies, IgM-κ paraprotein and additional autoimmune processes in association with a diffuse large B-cell non-Hodgkin's lymphoma.
Milnik A; Roggenbuck D; Conrad K; Bartels C
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23341581
[TBL] [Abstract][Full Text] [Related]
31. High-grade B-cell cerebral lymphoma in a patient with anti-myelin-associated glycoprotein IgM paraproteinemic neuropathy.
Ellie E; Vital A; Steck AJ; Julien J; Henry P; Vital C
Neurology; 1995 Feb; 45(2):378-81. PubMed ID: 7531825
[TBL] [Abstract][Full Text] [Related]
32. [Peripheral neuropathies associated with IgM monoclonal gammopathy: clinical and electrophysiological aspects].
Léger JM; Chassande B; Bouche P
Rev Neurol (Paris); 1996 May; 152(5):394-9. PubMed ID: 8881438
[TBL] [Abstract][Full Text] [Related]
33. Rituximab treatment of an IgM monoclonal autonomic and sensory neuropathy.
Goldfarb AR; Weimer LH; Brannagan TH
Muscle Nerve; 2005 Apr; 31(4):510-5. PubMed ID: 15685616
[TBL] [Abstract][Full Text] [Related]
34. Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).
Kvarnstrom M; Sidorova E; Nilsson J; Ekerfelt C; Vrethem M; Soderberg O; Johansson M; Rosen A; Ernerudh J
Clin Exp Immunol; 2002 Feb; 127(2):255-62. PubMed ID: 11876747
[TBL] [Abstract][Full Text] [Related]
35. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
[TBL] [Abstract][Full Text] [Related]
36. Paraproteinemic neuropathy.
Zivković SA; Lacomis D; Lentzsch S
Leuk Lymphoma; 2009 Sep; 50(9):1422-33. PubMed ID: 19637090
[TBL] [Abstract][Full Text] [Related]
37. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.
Yin CC; Lin P; Carney DA; Handy BC; Rassidakis GZ; Admirand JH; Keating MJ; Medeiros LJ
Am J Clin Pathol; 2005 Apr; 123(4):594-602. PubMed ID: 15743747
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal protein identified by an anomalous lipaemia index.
Monk C; Wallage M; Wassell J; Whiteway A; James J; Beetham R
Ann Clin Biochem; 2009 May; 46(Pt 3):250-2. PubMed ID: 19261678
[TBL] [Abstract][Full Text] [Related]
39. t(11;18)(q21;q21)-positive advanced-stage MALT lymphoma associated with monoclonal gammopathy: resistance to rituximab or rituximab-containing chemotherapy.
Ohno H; Isoda K
J Clin Exp Hematop; 2008 Nov; 48(2):47-54. PubMed ID: 19039196
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
Latov N
Ann Neurol; 1995 May; 37 Suppl 1():S32-42. PubMed ID: 8968215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]